Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2008
11/06/2008WO2008109719A3 Steroids derivatives as selective progesterone receptor modulators
11/06/2008US20080275258 antilipemic agents for regulation or prevention of obesity; food and tea drink; reacting a flavan-3-ol with formaldehyde; used in smaller amounts, plant extracts; enzyme inhibitor as hypotensive agents, antidiabetic agent, aging resistance, anticarcinogenic agent
11/06/2008US20080275257 Hydroxymethyl fluorescein derivatives for use as biological markers and dyes
11/06/2008US20080275237 purification by esterification, amidation and crystallization; trans-Tetrahydrocannabinol 2-naphthoyl ester intermediates; stereospecific enantiomorphs; cost efficiency, simplification; don't need chromatographic or distillative separation; narcotic drugs
11/06/2008US20080275215 Fluorescein-Based Compounds And Their Use For Peptide Synthesis
11/06/2008US20080275109 Drug, food or drink product containing proanthocyanidine derived from hop, hop bract or apple; prevents digestive diseases caused by Helicobacter pylori; freeze drying
11/06/2008US20080275017 Aromatic sulfenates for type i phototherapy
11/06/2008US20080274907 Fluorogenic ph sensitive dyes and their method of use
11/06/2008US20080274519 Using enzymatic conversion to generate genistein from catechins
11/06/2008US20080274492 Detection of platinum group metals with fluorophores via allylic oxidative insertion
11/06/2008CA2685739A1 Hydroxy sulfonate of quinone compounds and their uses
11/05/2008EP1988085A1 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-bezisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process
11/05/2008EP1987017A1 Radioligands for the 5 -ht1b receptor
11/05/2008EP1986635A2 Anticancer agents
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008CN101300246A Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101298450A Extraction and separation method of effective ingredients brevifolin and 8,9-single-epoxy brevifolin in phyllanthus simplex
11/05/2008CN101298449A Novel preparation of myricetin
11/05/2008CN100430391C Method for producing 2-[-5-(4-fluoprophenyl)-3-pyridylmethylaminomethyl]-chromane
11/04/2008US7446229 side effects reduction; cannabimimetic compounds; high binding affinities via substituted alkyl side chains at the c-3 position for at least one cannabinoid receptor; agonists; (4R)-4-[4-(2-hexyl-1,3-dithiolan-2-yl)-2,6-dihydroxyphenyl]-6,6-dimethyl-2 beta -norpinanol; may contain terpene funtionality
11/04/2008US7446198 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides
11/04/2008US7446124 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
10/2008
10/30/2008WO2008130322A1 Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
10/30/2008WO2008128344A1 Small-molecule hepatitis c virus (hcv) ns3/4a serine protease inhibitors
10/30/2008WO2007098205A3 Cocoa products and methods of treating cardiovascular conditions with sugar-free cocoa
10/30/2008US20080269510 New alpha-glucosidase inhibitors and antibacterial compounds from Myrtus communis L.
10/30/2008US20080269482 Use of Rylene Derivatives as Photosensitizers in Solar Cells
10/30/2008US20080269320 Cocoa Extracts
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/30/2008US20080268509 Methods of labeling polynucleotides with energy transfer dyes
10/29/2008EP1984317A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
10/29/2008EP1812417B1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
10/29/2008EP1697340B1 Process for purifying (-)-d9-trans-tetrahydrocannabinol
10/29/2008CN101296925A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296731A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN100429211C New technique for synthesizing 7,8 dihydroxyl coumarin
10/29/2008CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
10/28/2008US7442812 Substituted benzopyrans as selective estrogen receptor-beta agonists
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008CA2379981C Process for producing isocoumarins and intermediates for the same
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008US20080262248 Photochromic Spirodihydrophenanthropyrans
10/23/2008US20080262080 Allergy Suppressive Agent
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261905 Hexoses selected from tetrahydropyran; Preferred are hexitol, altritol, substituted altritols; novel modified nucleosides and nucleotides in single or double stranded oligonucleotides for RNA interference, antisense therapy; inhibit or decrease the expression of P-glycoprotein efflux pumps; cancer
10/23/2008US20080261898 Composition and method for cancer treatment and prevention
10/22/2008EP1982982A1 Novel coumarin derivative having antitumor activity
10/22/2008EP1981867A2 Method for preparing prostaglandin derivative
10/22/2008EP1417196B1 Dna-pk inhibitors
10/21/2008US7439265 irciniastatins, essentially pure, isolated from Indo-Pacific marine sponge Ircinia ramosa by cancer cell line bioassay-guided techniques; isochromene-pyran derivatives; dichloromethane-methanol extract; anticarcinogenic agent; P388 lymphocytic leukemia and pancreas, breast, CNS, lung cancer cell lines
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439077 Coumarin analog compounds for safer anticoagulant treatment
10/16/2008US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability
10/16/2008US20080254498 Fluorescent ion indicators and their applications
10/16/2008US20080254149 Solvent extraction of plant material from which oils have been distilled previously; phenolic compounds, flavones, isoflavones, glycosides, anthocyanins, proanthocyanidins, procyanidins, catechins, terpenes, lignins, tannins, glucosinilates, aliphatic and cyclic organic acids
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/15/2008EP1980248A1 Composition for treating cancer cells and synthetic method for the same
10/15/2008EP1979462A1 Use of cacao polyphenols in beer production
10/15/2008EP1979337A1 Chromen-4-one derivatives as a self-tanning substance
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008EP1689733B1 Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives
10/15/2008CN101285021A Process for simultaneously abstracting essential oil, chromocor and triterpenes components from agastache
10/15/2008CN101284022A Complexation extraction method of plant polyphenols substances
10/15/2008CN100425605C Method for extracting persimmon polyphenol from persimmon
10/14/2008US7435836 Esterification of a tocopherol with an acylating agent such as acetyl chloride or acetic anhydride in the presence of a solid basic alkali metal and/or alkaline earth metal catalyst, preferably on a solid carrier
10/14/2008US7435722 injection of curing agents selected from genipin, proanthocyanidin, ribose, threose, and lysyl oxidase into the convex side of intervertebral discs, to reduce bending hysteresis and increasing bending stiffness
10/14/2008US7435455 Wide temperature range of a nematic phase, a low viscosity, adequate optical anisotropy and a low threshold voltage, short response time, a low electric power consumption, a large contrast and a high voltage retention
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/09/2008WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008WO2008102397A3 Colchicine derivatives, process for their preparation and use in the medical field
10/09/2008WO2008055261A3 Therapeutic compounds
10/09/2008WO2008032105A3 Flavonoid derivatives and their uses
10/09/2008US20080249321 Fluorescent Probes
10/09/2008US20080249252 New permanent surface modifiers
10/09/2008US20080249163 Process For Producing Product Containing Proanthocyanidin in High Proportion
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080248990 Oxygen Containing Tri- or Tetra-Cyclic Terpenoid Compounds
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/08/2008EP1978022A1 Chromene compounds
10/08/2008EP1977646A1 Insecticidal hydroxyethyl thlourea derivatives
10/08/2008EP1976843A2 Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
10/08/2008EP1673363B1 Method for producing 1-hydroperoxy-16-oxabicyclo [10.4.0]hexadecane
10/08/2008EP1560819B1 Cannabinoid crystalline derivatives and process of cannabinoid purification
10/08/2008CN101282928A Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
10/08/2008CN101279967A Medicinal composition of trimethyl xanthone-4-acetic acid for treating cancer and use thereof
10/08/2008CN101279966A Optical isomer of Nipradilol, preparation and medical use thereof
10/08/2008CN101279915A Substituted phenol and application thereof as receptor TR3 excitant
10/08/2008CN101279901A Honokiol series derivates, preparation and use thereof
10/08/2008CN100424135C Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate
10/07/2008US7432298 Fluorescent polymeric materials containing lipid soluble rhodamine dyes
10/07/2008US7432297 composition is obtained by reacting resorcin, formaldehyde and methyl ethyl ketone in the presence of water, salts and acidic catalyst; adhesive for adhering wood with other organic materials and the like
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
10/05/2008CA2584087A1 Chemically patterned hydrogels, manufacture and use thereof
10/02/2008WO2008071951A3 Catalytic process for asymmetric hydrogenation
10/02/2008WO2007111864A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/02/2008US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis
10/01/2008EP1973895A1 Process for isolation of desired isomers of nebivolol intermediates
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 242